DrugTopics: Communicating facts can help boost HPV vaccination rates
UC expert: Pharmacists should counsel patients on HPV to avoid certain cancers later
University of Cincinnati faculty member Katelyn Johnson, PharmD, is the leading contributor in a DrugTopics article on the human papillomavirus (HPV) and the HPV vaccine.
“As highly accessible healthcare professionals, pharmacists are equipped to identify patients who should receive the HPV vaccine and increase vaccination rates to assist with disease prevention,” said Johnson, an assistant professor of pharmacy practice and community pharmacist at UC's James L. Winkle College of Pharmacy.
An estimated 80% of Americans will be infected with human papillomavirus (HPV) at some point. For many people, the infection will clear on its own without causing symptoms; for others, it can cause cancer later in life.
Featured image at top of Katelyn Johnson/Colleen Kelley/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
The subtle changes in hearing you should never ignore
July 24, 2026
It’s easy to dismiss changes in hearing as minor. But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people don’t recognize — known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days.
UC experts say proper produce washing is key defense against Cyclospora
July 24, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
What are the options for male birth control?
July 24, 2026
Despite major advances in contraception during the past several decades, responsibility for pregnancy prevention falls largely on women. As recently reported in Endocrinology Advisor, a new generation of male contraceptive candidates is advancing into early- and mid-stage clinical trials.